This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • An open-label study to compare the prognostic valu...
Clinical trial

An open-label study to compare the prognostic value of (18F)Flutemetamol PET-imaging with longitudinal biomarker data in healthy volunteers and patients with mild cognitive impairment

Read time: 1 mins
Last updated:19th Jan 2012
To examine the efficacy of raised [18F]Flutemetamol brain uptake for differentiating subjects with mild cognitive impairment (MCI), who subsequently will develop Alzheimer´┐Żs disease (AD), from patients with MCI who will be cognitively stable or develop other dementias than AD
Category Value
Study start date 2012-01-19

View full details